These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22130579)

  • 41. Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease.
    Liang X; Wang P; Chen B; Ge Y; Gong AY; Flickinger B; Malhotra DK; Wang LJ; Dworkin LD; Liu Z; Gong R
    Kidney Int; 2020 Jan; 97(1):175-192. PubMed ID: 31791666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased expression of mast cells in reflux nephropathy.
    Solari V; Unemoto K; Piaseczna Piotrowska A; Puri P
    Pediatr Nephrol; 2004 Feb; 19(2):157-63. PubMed ID: 14677055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis.
    Ehara T; Shigematsu H
    Kidney Int; 1998 Nov; 54(5):1675-83. PubMed ID: 9844144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy.
    Verzola D; Gandolfo MT; Gaetani G; Ferraris A; Mangerini R; Ferrario F; Villaggio B; Gianiorio F; Tosetti F; Weiss U; Traverso P; Mji M; Deferrari G; Garibotto G
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1563-73. PubMed ID: 18768588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TRAIL treatment prevents renal morphological changes and TGF-β-induced mesenchymal transition associated with diabetic nephropathy.
    Toffoli B; Tonon F; Tisato V; Michelli A; Zauli G; Secchiero P; Fabris B; Bernardi S
    Clin Sci (Lond); 2020 Sep; 134(17):2337-2352. PubMed ID: 32857135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
    Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
    Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy.
    Yamashita T; Fujimiya M; Nagaishi K; Ataka K; Tanaka M; Yoshida H; Tsuchihashi K; Shimamoto K; Miura T
    FASEB J; 2012 Apr; 26(4):1559-68. PubMed ID: 22198389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Urinary excretion of fibrogenic and antifibrotic growth factors in type 1 diabetic patients: the interrelationship with diabetic nephropathy].
    Bondar' IA; Klimontov VV; Parfent'eva EM; Romanov VV; Nadeev AP
    Ter Arkh; 2012; 84(6):36-40. PubMed ID: 22997916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis.
    Lewis A; Steadman R; Manley P; Craig K; de la Motte C; Hascall V; Phillips AO
    Histol Histopathol; 2008 Jun; 23(6):731-9. PubMed ID: 18366011
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study.
    Ito H; Komatsu Y; Mifune M; Antoku S; Ishida H; Takeuchi Y; Togane M
    Cardiovasc Diabetol; 2010 May; 9():18. PubMed ID: 20470427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Euterpe oleracea Mart. seed extract protects against renal injury in diabetic and spontaneously hypertensive rats: role of inflammation and oxidative stress.
    da Silva Cristino Cordeiro V; de Bem GF; da Costa CA; Santos IB; de Carvalho LCRM; Ognibene DT; da Rocha APM; de Carvalho JJ; de Moura RS; Resende AC
    Eur J Nutr; 2018 Mar; 57(2):817-832. PubMed ID: 28105508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of tubular epithelial cells in diabetic nephropathy.
    Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
    Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenic role of cardiac mast cell activation/degranulation,TNF-alpha, and cell death in acute drug-related fatalities.
    Perskvist N; Söderberg C; van Hage M; Edston E
    Vasc Health Risk Manag; 2007; 3(6):1053-62. PubMed ID: 18200824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
    Morii T; Fujita H; Narita T; Shimotomai T; Fujishima H; Yoshioka N; Imai H; Kakei M; Ito S
    J Diabetes Complications; 2003; 17(1):11-5. PubMed ID: 12505750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
    Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
    Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy.
    Yao Y; Fomison-Nurse IC; Harrison JC; Walker RJ; Davis G; Sammut IA
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F251-62. PubMed ID: 24899056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of lncRNA MALAT1 contributes to renal functional improvement after duodenal-jejunal bypass in a diabetic rat model.
    Wu D; Cheng YG; Huang X; Zhong MW; Liu SZ; Hu SY
    J Physiol Biochem; 2018 Aug; 74(3):431-439. PubMed ID: 29781038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and histological correlation of diabetic nephropathy.
    Afroz T; Sagar R; Reddy S; Gandhe S; Rajaram KG
    Saudi J Kidney Dis Transpl; 2017; 28(4):836-841. PubMed ID: 28748886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.